In vitro susceptibilities of clinical yeast isolates to the new antifungal eberconazole compared with their susceptibilities to clotrimazole and ketoconazole.

Torres-Rodríguez, J M; Mendez, R; López-Jodra, O; Morera, Y; Espasa, M; Jimenez, T; Lagunas, C

Torres-Rodríguez, J M; Mendez, R; López-Jodra, O; Morera, Y; Espasa, M; Jimenez, T; Lagunas, C.

Affiliation

Torres-Rodríguez JM; Experimental and Clinical Mycology Research Group (GREMEC), IMIM, Autonomous University of Barcelona, Barcelona, Spain. jmtorres@imim.es

Antimicrob Agents Chemother ; 43(5): 1258-9, 1999 May.

Article in En | MEDLINE | ID: mdl-10223946

Subject(s)

Antifungal Agents/pharmacology; Candida/drug effects; Clotrimazole/pharmacology; Cryptococcus/drug effects; Cycloheptanes/pharmacology; Imidazoles/pharmacology; Ketoconazole/pharmacology; Antifungal Agents/chemistry; Imidazoles/chemistry; Microbial Sensitivity Tests

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Candida / Clotrimazole / Cryptococcus / Cycloheptanes / Imidazoles / Ketoconazole / Antifungal Agents Type of study: Guideline Language: En Journal: Antimicrob Agents Chemother Year: 1999 Document type: Article Affiliation country: Spain Country of publication: United States

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google